scholarly article | Q13442814 |
P356 | DOI | 10.1074/JBC.M305082200 |
P698 | PubMed publication ID | 12819191 |
P50 | author | Kevin A Reynolds | Q39776338 |
P2093 | author name string | Yasuyo Sekiyama | |
Hiroyuki Osada | |||
Beom Seok Kim | |||
Nadaraj Palaniappan | |||
P2860 | cites work | Basic local alignment search tool | Q25938991 |
Insights into channel architecture and substrate specificity from crystal structures of two macrocycle-forming thioesterases of modular polyketide synthases | Q27639797 | ||
Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2) | Q29547307 | ||
PCR-targeted Streptomyces gene replacement identifies a protein domain needed for biosynthesis of the sesquiterpene soil odor geosmin | Q30764407 | ||
Forty years of genetics with Streptomyces: from in vivo through in vitro to in silico | Q33750125 | ||
Genetic manipulation of antibiotic-producing Streptomyces | Q34460859 | ||
Protein phosphatase 2A enhances activation of human immunodeficiency virus type 1 by phorbol myristate acetate | Q34467506 | ||
Studies on new phosphate ester antifungal antibiotics phoslactomycins. I. Taxonomy, fermentation, purification and biological activities | Q34537784 | ||
Cloning and characterization of the bleomycin biosynthetic gene cluster from Streptomyces verticillus ATCC15003. | Q34574218 | ||
Fostriecin: chemistry and biology | Q34946202 | ||
Cloning and characterization of the gene encoding 1-cyclohexenylcarbonyl coenzyme A reductase from Streptomyces collinus | Q35617514 | ||
Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin. | Q36618801 | ||
Novel microbial metabolites of the phoslactomycins family induce production of colony-stimulating factors by bone marrow stromal cells. I. Taxonomy, fermentation and biological properties. | Q41526014 | ||
Gene disruption and replacement in the rapamycin-producing Streptomyces hygroscopicus strain ATCC 29253. | Q42652431 | ||
Protein phosphatase 2A inhibitors, phoslactomycins. Effects on the cytoskeleton in NIH/3T3 cells | Q42816538 | ||
Identification of a cyclohexylcarbonyl CoA biosynthetic gene cluster and application in the production of doramectin | Q43169457 | ||
Biochemical evidence for an editing role of thioesterase II in the biosynthesis of the polyketide pikromycin | Q44170594 | ||
Expression, site-directed mutagenesis, and steady state kinetic analysis of the terminal thioesterase domain of the methymycin/picromycin polyketide synthase | Q44178730 | ||
A model of structure and catalysis for ketoreductase domains in modular polyketide synthases | Q44270898 | ||
Biosynthesis of ansatrienin (mycotrienin) and naphthomycin. Identification and analysis of two separate biosynthetic gene clusters in Streptomyces collinus Tü 1892. | Q44857679 | ||
A novel delta(3),delta(2)-enoyl-CoA isomerase involved in the biosynthesis of the cyclohexanecarboxylic acid-derived moiety of the polyketide ansatrienin A. | Q44872960 | ||
Total synthesis of fostriecin (CI-920). | Q46759738 | ||
Fostriecin, an inhibitor of protein phosphatase 2A, limits myocardial infarct size even when administered after onset of ischemia | Q47281388 | ||
Hydroxylation of macrolactones YC-17 and narbomycin is mediated by the pikC-encoded cytochrome P450 in Streptomyces venezuelae | Q48005296 | ||
Protein phosphatase inhibitors calyculin A and fostriecin protect rabbit cardiomyocytes in late ischemia. | Q50525204 | ||
Comparison of in vitro preconditioning responses of isolated pig and rabbit cardiomyocytes: effects of a protein phosphatase inhibitor, fostriecin. | Q50525405 | ||
FramePlot: a new implementation of the frame analysis for predicting protein-coding regions in bacterial DNA with a high G + C content. | Q53931796 | ||
Isolation and structure of phosphazomycin C | Q68717070 | ||
A new antifungal antibiotic, phosphazomycin A | Q69803431 | ||
Novel microbial metabolites of the phoslactomycins family induce production of colony-stimulating factors by bone marrow stromal cells. II. Isolation, physico-chemical properties and structure determination | Q71599514 | ||
Specific inhibitors of protein phosphatase 2A inhibit tumor metastasis through augmentation of natural killer cells | Q72998634 | ||
Formal catalytic asymmetric total synthesis of fostriecin | Q73046786 | ||
Asymmetric total synthesis of (+)-fostriecin | Q77762764 | ||
Studies of new phosphate ester antifungal antibiotics phoslactomycins. II. Structure elucidation of phoslactomycins A to F. | Q78420416 | ||
Formal total synthesis of fostriecin | Q78684154 | ||
Biosynthesis of ansatrienin. Nonincorporation of shikimic acid into the mC7N unit and stereochemistry of its conversion to the cyclohexanecarboxylic acid moiety | Q105314335 | ||
P433 | issue | 37 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 35552-35557 | |
P577 | publication date | 2003-06-20 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Enhancement and selective production of phoslactomycin B, a protein phosphatase IIa inhibitor, through identification and engineering of the corresponding biosynthetic gene cluster | |
P478 | volume | 278 |